Rite Aid moved 1.0% this morning session, trading between a high of $1.56 and a low of $1.52 per share. Yesterday the stock finished at $1.51 per share, compared to an average analyst target price of $1.0.
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The small-cap retail-drug stores and proprietary stores company is based in the United States. Rite Aid has trailing twelve months earnings per share (EPS) of -15.59, which at today's prices amounts to a price to earnings (P/E) ratio of -0.1.
Based on its expected future earnings growth, the company has a price to earnings growth (PEG) ratio of 0.11. Usually a PEG ratio between 0 and 1 indicates a potentially undervalued company.
Overview of the Company's Gross Margins:
| Date Reported | Revenue ($ k) | Cost of Revenue ($ k) | Gross Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023-02-28 | 24,091,899 | 19,287,959 | 19.94 | -4.04 |
| 2022-02-28 | 24,568,255 | 19,461,760 | 20.78 | 6.18 |
| 2021-02-28 | 24,043,240 | 19,338,918 | 19.57 | -9.23 |
| 2020-02-29 | 21,928,393 | 17,201,635 | 21.56 | n/a |
Rite Aid's 20.5% average gross margins are thinner than the 23.25% average of the Pharmaceutical Retail industry, implying that the firm might be lacking in competitivity.
